Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1995;3(6):241–244. doi: 10.1155/S1064744995000718

Randomized Trial of Erythromycin and Azithromycin for Treatment of Chlamydial Infection in Pregnancy

Marc F Rosenn 1,3,✉, George A Macones 1,2, Neil S Silverman 1
PMCID: PMC2364446  PMID: 18476049

Abstract

Objective: The purpose of this study was to compare erythromycin and azithromycin in the treatment of chlamydial cervicitis during pregnancy with regard to efficacy, side effects, and compliance.

Methods: In a prospective manner, 48 pregnant patients with cervical chlamydial infections diagnosed by routine screening tests were randomly assigned to receive either erythromycin, 500 mg q.i.d. for 7 days (N = 24), or azithromycin, 1 g as a one-time dose (N = 24). All sexual partners were given prescriptions for doxycycline, 100 mg b.i.d. for 7 days. The treatment efficacy was assessed by follow-up chlamydia testing 3 weeks after the therapy was completed. The side effects, intolerance to therapy, and overall compliance were evaluated by means of a standardized posttreatment questionnaire.

Results: There was no significant difference in cure rates noted between the erythromycin group and the azithromycin group (77% vs. 91%, respectively; P = 0.24). Gastrointestinal side effects were reported more frequently among patients treated with erythromycin compared with patients treated with azithromycin (45% vs. 17%, respectively; P = 0.004). The patients who received erythromycin reported intolerance to therapy secondary to side effects more frequently than patients who received azithromycin (23% vs. 4%, respectively; P = 0.07). Furthermore, the patients in the azithromycin group were more likely to complete their course of therapy as prescribed than the patients in the erythromycin group (100% vs. 61%, respectively; P = 0.002).

Conclusions: Azithromycin is efficacious and well tolerated for the treatment of chlamydial cervicitis in pregnancy. Erythromycin, though efficacious, is poorly tolerated, as demonstrated by the number of patients reporting significant side effects during the course of therapy. Since the cost of azithromycin is comparable to that of generic erythromycin, the present study supports the use of azithromycin as an alternative to erythromycin for the treatment of chlamydial cervicitis in pregnancy.

Full Text

The Full Text of this article is available as a PDF (369.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alary M., Joly J. R., Moutquin J. M., Mondor M., Boucher M., Fortier A., Pinault J. J., Paris G., Carrier S., Chamberland H. Randomised comparison of amoxycillin and erythromycin in treatment of genital chlamydial infection in pregnancy. Lancet. 1994 Nov 26;344(8935):1461–1465. doi: 10.1016/s0140-6736(94)90288-7. [DOI] [PubMed] [Google Scholar]
  2. Bass C. A., Jungkind D. L., Silverman N. S., Bondi J. M. Clinical evaluation of a new polymerase chain reaction assay for detection of Chlamydia trachomatis in endocervical specimens. J Clin Microbiol. 1993 Oct;31(10):2648–2653. doi: 10.1128/jcm.31.10.2648-2653.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bush M. R., Rosa C. Azithromycin and erythromycin in the treatment of cervical chlamydial infection during pregnancy. Obstet Gynecol. 1994 Jul;84(1):61–63. [PubMed] [Google Scholar]
  4. Cramer J. A., Scheyer R. D., Mattson R. H. Compliance declines between clinic visits. Arch Intern Med. 1990 Jul;150(7):1509–1510. [PubMed] [Google Scholar]
  5. Gravett M. G., Nelson H. P., DeRouen T., Critchlow C., Eschenbach D. A., Holmes K. K. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA. 1986 Oct 10;256(14):1899–1903. [PubMed] [Google Scholar]
  6. Harrison H. R., Alexander E. R., Weinstein L., Lewis M., Nash M., Sim D. A. Cervical Chlamydia trachomatis and mycoplasmal infections in pregnancy. Epidemiology and outcomes. JAMA. 1983 Oct 7;250(13):1721–1727. [PubMed] [Google Scholar]
  7. Harrison H. R., English M. G., Lee C. K., Alexander E. R. Chlamydia trachomatis infant pneumonitis: comparison with matched controls and other infant pneumonitis. N Engl J Med. 1978 Mar 30;298(13):702–708. doi: 10.1056/NEJM197803302981303. [DOI] [PubMed] [Google Scholar]
  8. Martin D. H., Koutsky L., Eschenbach D. A., Daling J. R., Alexander E. R., Benedetti J. K., Holmes K. K. Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infections. JAMA. 1982 Mar 19;247(11):1585–1588. [PubMed] [Google Scholar]
  9. Martin D. H., Mroczkowski T. F., Dalu Z. A., McCarty J., Jones R. B., Hopkins S. J., Johnson R. B. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. N Engl J Med. 1992 Sep 24;327(13):921–925. doi: 10.1056/NEJM199209243271304. [DOI] [PubMed] [Google Scholar]
  10. McGregor J. A., French J. I. Chlamydia trachomatis infection during pregnancy. Am J Obstet Gynecol. 1991 Jun;164(6 Pt 2):1782–1789. doi: 10.1016/0002-9378(91)90560-e. [DOI] [PubMed] [Google Scholar]
  11. Ryan G. M., Jr, Abdella T. N., McNeeley S. G., Baselski V. S., Drummond D. E. Chlamydia trachomatis infection in pregnancy and effect of treatment on outcome. Am J Obstet Gynecol. 1990 Jan;162(1):34–39. doi: 10.1016/0002-9378(90)90815-o. [DOI] [PubMed] [Google Scholar]
  12. Schachter J., Grossman M., Sweet R. L., Holt J., Jordan C., Bishop E. Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA. 1986 Jun 27;255(24):3374–3377. [PubMed] [Google Scholar]
  13. Schachter J., Sweet R. L., Grossman M., Landers D., Robbie M., Bishop E. Experience with the routine use of erythromycin for chlamydial infections in pregnancy. N Engl J Med. 1986 Jan 30;314(5):276–279. doi: 10.1056/NEJM198601303140503. [DOI] [PubMed] [Google Scholar]
  14. Scieux C., Bianchi A., Chappey B., Vassias I., Pérol Y. In-vitro activity of azithromycin against Chlamydia trachomatis. J Antimicrob Chemother. 1990 Jan;25 (Suppl A):7–10. doi: 10.1093/jac/25.suppl_a.7. [DOI] [PubMed] [Google Scholar]
  15. Silverman N. S., Sullivan M., Hochman M., Womack M., Jungkind D. L. A randomized, prospective trial comparing amoxicillin and erythromycin for the treatment of Chlamydia trachomatis in pregnancy. Am J Obstet Gynecol. 1994 Mar;170(3):829–832. doi: 10.1016/s0002-9378(94)70292-6. [DOI] [PubMed] [Google Scholar]
  16. Steingrimsson O., Olafsson J. H., Thorarinsson H., Ryan R. W., Johnson R. B., Tilton R. C. Azithromycin in the treatment of sexually transmitted disease. J Antimicrob Chemother. 1990 Jan;25 (Suppl A):109–114. doi: 10.1093/jac/25.suppl_a.109. [DOI] [PubMed] [Google Scholar]
  17. Sweet R. L., Landers D. V., Walker C., Schachter J. Chlamydia trachomatis infection and pregnancy outcome. Am J Obstet Gynecol. 1987 Apr;156(4):824–833. doi: 10.1016/0002-9378(87)90338-3. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES